You are on Trendlyne United States. Click here to go to India website or make United States as your default
person reading

About Supernus Pharmaceuticals Inc - Company Information, Overview, History and Profile

What does Supernus Pharmaceuticals Inc do?

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Supernus Pharmaceuticals Inc Management structure

All Gross Remunerations are in USD
Ms. Tami Tillotson Martin, Esq.,R.N.
Senior Vice President, Regulatory Affairs
-
2024
Gross Remuneration
Year
Dr. Roman Bradel, PhD
Vice President, Regulatory Affairs
-
2024
Gross Remuneration
Year

Supernus Pharmaceuticals Inc Board of directors

All Gross Remunerations are in USD
Dr. John M. Siebert,PhD
Independent Director
-
2024
Gross Remuneration
Year